论文信息 - A Phase II Study of Bortezomib (Velcade ®), Cyclophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma - 字舞流文

A Phase II Study of Bortezomib (Velcade ®), Cyclophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma

D. Esseltine | S. Jagannath | D. Vesole | B. Durie | J. Crowley | P. Becker | W. Bensinger | D. Irwin | A. Mazumder | J. Wolf | Gerardo Capo | R. Vescio | E. Camacho | M. McKinley | P. Potts | G. Capo